Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-065310

Options or other derivatives

  • Chief Operating Officer acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hensley Mark Earl Chief Operating Officer 2025-05-06 Grant or award · Restricted Stock Units +500,000 500,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…